⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
mTOR and Nutrient Sensing
Current understanding
The central growth-vs-maintenance switch; where rapamycin, protein, and fasting stories converge.
Evidence log
- 2026-11-13 — Functional contribution of TERT to mitigation of endometrial stromal cell senescence by metformin through modulation of the AKT/mTOR axis.: [animal-model] Endometrial stromal cell experiments and an aged-mouse study connect metformin’s anti-senescence effects to functional involvement of TERT and modulation of the AKT/mTOR axis, alongside improved uterine histology and litter size, without establishing human efficacy or a general reproductive benefit from mTOR inhibition. [animal-model] (novelty: 3)
- 2026-11-13 — Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation.: [animal-model] A mouse study reports that heterozygous leptin receptor deficiency (db/+) accelerates age-dependent metabolic dysfunction and Alzheimer-like neuropathology with CDK5 hyperactivation, tau hyperphosphorylation, and synaptic gene downregulation, extending the endocrine nutrient-sensing evidence without establishing direct mTOR involvement or human therapeutic benefit. [animal-model] (novelty: 3)
- 2026-11-09 — Epigenetic age acceleration in the brain and blood of people with epilepsy and in a mouse model of focal cortical dysplasia: a retrospective cross-sectional study.: [animal-model] In an mTOR-driven mouse model of focal cortical dysplasia, brain epigenetic aging signatures appeared before seizure onset, placing the clock signal temporally upstream of seizures in this model without establishing that it causes seizures or that mTOR inhibition reverses brain aging in humans. [animal-model] (novelty: 3)
- 2026-11-04 — Longitudinal associations between the hallmarks of aging and body composition: a narrative review.: [human-observational] A narrative review of 50 longitudinal human studies mapping aging hallmarks to muscle, bone, and adipose remodeling found evidence concentrated in deregulated nutrient sensing and chronic inflammation, without establishing mTOR-specific causality or benefit from nutrient-sensing interventions. [human-observational] (novelty: 3)
- 2026-11-06 — Adipocyte FGF21 signalling connects protein restriction and metabolic cellular ageing.: [animal-model] A preclinical study reports that adipocyte FGF21 signaling mediates cellular and metabolic anti-aging effects of dietary protein restriction, identifying a tissue-specific endocrine conduit within the nutrient-restriction response without establishing direct mTOR involvement, lifespan extension, or human benefit. [animal-model] (novelty: 3)
- 2026-11-01 — Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1-Dependent Suppression of ROMK.: [animal-model] A mouse study identified mTORC1-dependent suppression of the distal renal ROMK potassium channel under Klotho deficiency, with rapamycin or Klotho supplementation rescuing impaired potassium handling; human efficacy and safety for this indication remain unestablished. [animal-model] (novelty: 3)
- 2026-10-19 — Cell type-dependent activation of autophagic flux by D-amino acids.: [mechanism-plausible] Human cell-line experiments report that specific D-amino acids increase autophagic flux without suppressing mTORC1, identifying an amino-acid-responsive route distinct from canonical mTORC1 inhibition in the tested cells, with no established human intervention benefit. [mechanism-plausible] (novelty: 3)
- 2026-11-05 — Rapamycin and human longevity among kidney transplant recipients surviving the first year.: [human-observational] A propensity-score-weighted observational cohort of over 11,000 kidney transplant recipients surviving the first post-transplant year, followed for a median of 11 years, found chronic rapamycin exposure was not associated with improved long-term survival; residual confounding and the transplant-treatment context limit causal inference and extrapolation to longevity use in otherwise healthy people. [human-observational] (novelty: 4)
- 2026-11-01 — Constitutive Activation of Skeletal Muscle mTORC1 Drives Pro-Inflammatory Gene Expression in Skeletal Muscle of Aged Mice.: [animal-model] In 27-month-old mice, muscle-specific Depdc5 knockout constitutively activated mTORC1 and increased skeletal-muscle pro-inflammatory gene expression and TNF-α protein, extending the existing adult-mouse finding into advanced age; dietary rapamycin provided only partial rescue without suppressing the induced inflammatory markers, with no human translation established. [animal-model] (novelty: 3)
- 2026-09-27 — Lifespan-extending downregulation of insulin signalling reduces germline mutation load: C. elegans mutation-accumulation WGS study: adult-onset downregulation of insulin/IGF-1 signalling extended lifespan while cutting germline single-nucleotide mutation load by up to ~50% and blocking UV-induced mutagenesis, in an HRDE-1-dependent manner — reframes IIS as coordinating somatic and germline maintenance rather than trading them off, worm-only. [animal-model] (novelty: 4)
- 2026-09-29 — Direct Pharmacological Activation of AMPK Extends Lifespan in Yeast, Worms and Flies: Cross-species invertebrate study (yeast, C. elegans, Drosophila) reports direct pharmacological AMPK activation extends lifespan in all three models, strengthening AMPK — the catabolic counterpart to mTORC1 on this page — as a conserved druggable longevity node, though no mammalian or human outcome data. [animal-model] (novelty: 3)
- 2026-09-01 — Interferon Regulatory Factor 1 Inhibits the Adipogenic Differentiation of BMSCs via the AMPK-mTOR Signaling Axis and Induces Their Autophagy to Alleviate Osteoporosis-Related Bone Marrow Adiposity.: Preclinical BMSC + OVX/aged mouse study: IRF1 overexpression activates AMPK and suppresses mTOR in bone marrow mesenchymal stem cells to inhibit adipogenic differentiation and reduce osteoporosis-related marrow adiposity, adding IRF1 as an upstream transcription-factor input to the AMPK–mTOR axis in a stromal-progenitor fate context. [animal-model] (novelty: 3)
- 2026-09-03 — Aging microenvironment induces CD8T cell exhaustion by suppressing hepatic β-hydroxybutyrylate synthesis.: Preclinical mouse study ties age-related decline in hepatic BDH1 ketogenesis to CD8 T-cell exhaustion via loss of PRKAR1B β-hydroxybutyrylation, adding a hepatic ketone-body arm (3HB as both metabolic fuel and PTM substrate) to the nutrient-sensing roster — adjacent to AMPK/fasting biology, with 3HB supplementation rescuing aged immune function. [animal-model] (novelty: 4)
- 2026-10-06 — Sex-stratified immune patterns across the canine lifespan and short-term responses to geroprotective interventions.: cross-connection with companion-dog-aging-model: 90-day Beagle intervention arms place rapamycin’s exploratory cytokine footprint ahead of canagliflozin and dietary restriction in a non-rodent mammal, linking the dog translational model directly to the mTOR-inhibition node. (novelty: 3)
- 2026-07-12 — Biological limits of lifespan extension: Evidence for a shift from pathway leverage to system-level buffering across species.: 2026 comparative review positions mTOR/IIS as a prototypical ‘high-leverage’ pathway whose lifespan-extension ceiling erodes as organismal complexity rises, offering a framework reason why rapamycin’s rodent effect sizes are smaller than those seen in worms and flies — synthesis, no new mTOR data. [expert-opinion] (novelty: 3)
- 2026-10-06 — PI3K is the dominant signalling pathway recruited by IRS proteins to mediate their effects on metabolism and growth.: Knock-in mouse genetics separating IRS1/IRS2 adaptor outputs show PI3K recruitment is the dominant mediator of insulin/IGF-1 growth and metabolic phenotypes, while GRB2/MAPK recruitment is dispensable — clarifies which branch downstream of IIS feeds the PI3K–AKT–mTOR arm versus the Ras–MAPK arm. [animal-model] (novelty: 3)
- 2026-10-01 — Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice.: Aged ApoE/LDLR-context mouse study: therapeutic rapamycin remodeled plaque macrophage content and lymphoid immune responses toward Treg-enriched/regulatory phenotypes with suppressed senescent-leukocyte scores, extending the preclinical mTOR-inhibition story from atrial/cardiac remodeling into established aged-atherosclerotic plaque immunity with scRNA-seq resolution. [animal-model] (novelty: 3)
- 2026-08-18 — The nutrition-sleep-circadian axis in age-related neurodegeneration: Cellular mechanisms, metabolic dysfunction, and neuroprotective interventions.: 2026 nutrition–sleep–circadian–neurodegeneration review implicates nutrient-sensing/metabolic dysfunction tied to meal timing and sleep disruption as part of the axis driving AD/PD risk, with chrononutrition and time-restricted feeding nominated as levers acting through this arm — framing claim, no mTOR/AMPK endpoints. [expert-opinion] (novelty: 3)
- 2026-08-10 — Chronic subdural hematoma through the hallmarks of aging: a geroscience framework for the commonest neurosurgical condition of older adults.: 2026 CSDH geroscience minireview includes deregulated nutrient sensing among the twelve hallmarks mapped onto chronic subdural hematoma, as a weaker contributor relative to inflammation and altered intercellular communication — framing claim, no nutrient-sensing pathway data in CSDH tissue. [expert-opinion] (novelty: 3)
- 2026-07-13 — PFDA exposure promotes myocardial aging and fibrosis via hyperactivation of the MTORC1 signaling axis.: 2026 preclinical PFDA exposure study: the perfluoroalkyl pollutant PFDA hyperactivates MTORC1 in cardiomyocytes to drive senescence and myocardial fibrosis — nominates an environmental PFAS toxicant as an upstream driver of pathological mTORC1 tone in cardiac tissue, extending the environmental-exposure arm of mTOR dysregulation beyond cigarette-smoke RPE and high-protein-diet models. [animal-model] (novelty: 3)
- 2026-07-24 — Circulating factors induced by time-restricted eating drive metabolic reprogramming in endothelial cells.: Ex vivo serum-transfer study: serum from aged humans practicing time-restricted eating suppressed mTORC1 and activated ISR/ATF4 in cultured human cerebromicrovascular endothelial cells, offering a specific circulating-factor route linking a human lifestyle intervention to endothelial nutrient-sensing tone — no in vivo endothelial or clinical readout. [mechanism-plausible] (novelty: 3)
- 2026-08-04 — Aging preserves mTORC1 but attenuates JNK-SMAD2L signaling sensitivity to passive stretch-induced tension development in isolated mouse skeletal muscle.: Isolated aged mouse EDL ex vivo: passive stretch–induced tension preserved mTORC1 activation but attenuated JNK–SMAD2L signaling, dissociating the anabolic (mTORC1) arm of mechanotransduction from a tension-sensitive transcriptional arm in aging muscle. [animal-model] (novelty: 3)
- 2026-01-26 — High-protein diet promotes aging by activating the CG6415/AMT gene and disrupting mitochondrial homeostasis.: Drosophila + human cell study implicates dietary isoleucine (and high protein more broadly) in activating CG6415/AMT to drive mitochondrial OXPHOS inhibition and p53–p21 aging, adding a specific branched-chain-amino-acid–responsive effector downstream of protein-sensing distinct from canonical mTORC1 translation outputs; preclinical. [animal-model] (novelty: 3)
- 2026-09-23 — Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice: 2026 aged atherosclerotic mouse study: therapeutic rapamycin reprogrammed immune responses to attenuate plaque and lymphoid inflammation, extending mTOR-inhibition’s preclinical repertoire from cardiac/atrial remodeling to established atherosclerotic plaque biology in aged animals. [animal-model] (novelty: 3)
- 2026-09-12 — Age-related IGF-1 decline permits a redox-sensitive transcriptional shift that directs hematopoiesis toward a CCR2myeloid fate.: Preclinical study localizes an age-related IGF-1 decline to the bone-marrow niche and ties it to HSC fate skewing, extending the IGF-1 arm of nutrient-sensing biology from systemic/hepatic tone to a tissue-local hematopoietic phenotype (redox/NF-κB/IRF8 → CCR2+ myeloid trajectory). [animal-model] (novelty: 3)
- 2026-09-15 — Hepassocin prevents age-related liver senescence and facilitates liver regeneration by activating AMPK.: 2026 aged-mouse study: age-related decline of the hepatokine hepassocin lowers hepatic AMPK activation via an ANXA2–ERK–p90RSK–LKB1 cascade, and exogenous HPS or AICAR restores AMPK tone and rescues liver senescence/regeneration — adds a liver-secreted factor upstream of the LKB1–AMPK arm of nutrient sensing. [animal-model] (novelty: 3)
- 2026-09-16 — Retrotransposable element derepression distinguishes DNMT3A-mutant from TET2-mutant clonal haematopoiesis.: Human observational CH profiling: TET2-mutant clones (but not DNMT3A) enrich OXPHOS, ROS, and mTORC1 pathway signatures, nominating a TET2-specific metabolic/nutrient-sensing tilt as the alternative axis to the DNMT3A RTE-inflammation route. [human-observational] (novelty: 3)
- 2026-08-31 — A cross-species drug-discovery platform to accelerate the identification of lifespan-extending interventions.: Cross-species (yeast→mouse) 400+ compound lifespan-screening platform reports multi-species geroprotectors converging on conserved longevity pathways, of which nutrient-sensing (mTOR/IIS) is expected to be central; specific hits and human data not disclosed in abstract. [animal-model] (novelty: 4)
- 2026-09-16 — Aging as Loss of Biological Self-Correction: A Geroscience Framework for Longevity, Inflammaging, and Restored Resilience.: 2026 self-correction framework review situates nutrient-sensing pathways as sense-and-scale nodes whose loss of dynamic responsiveness (not steady-state tone) drives aging phenotypes; conceptual reframing, no new mTOR/AMPK data. [expert-opinion] (novelty: 3)
- 2026-09-23 — Lsp2 links early-life diet to adult translation and lifespan in Drosophila.: Drosophila study shows early-life protein restriction extends adult lifespan by durably downregulating the storage protein Lsp2, lowering early-adult ribosomal-protein abundance and translational capacity; restriction of phenylalanine or tyrosine alone reproduces the effect, positioning Lsp2 as a developmental carrier of amino-acid status into adult mTOR/translation tone. [animal-model] (novelty: 3)
- 2026-09-23 — Lsp2 links mTORC1 to TOP mRNA translation and lifespan in Drosophila.: Drosophila study identifies Lsp2 as a nutrient-induced adipose effector that amplifies mTORC1-driven 4E-BP-dependent TOP mRNA translation; Lsp2 loss extends lifespan without impairing life-history traits via a path distinct from rapamycin, adding a translation-selective downstream node to the mTOR–longevity axis. [animal-model] (novelty: 4)
- 2026-09-18 — Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.: 2026 selenium–sarcopenia review links selenoprotein activity to muscle protein-homeostasis maintenance in aging, positioning selenium as a micronutrient input relevant to (though not mechanistically resolved with) nutrient-sensing–driven anabolic control; connection is inferential rather than demonstrated. [mechanism-plausible] (novelty: 3)
- 2026-09-18 — Imeglimin provides dual hepatic and skeletal muscle protection in experimental MASH-associated sarcopenia.: Preclinical MASH-sarcopenia study: imeglimin restored AKT–mTOR anabolic signaling and NAD+/NAMPT tone in skeletal muscle while preserving muscle mass, without altering fasting glucose or insulin — dissociates the drug’s nutrient-sensing / anabolic-axis engagement from its canonical glycemic action. [animal-model] (novelty: 3) [animal-model] (novelty: 3)
- 2026-09-10 — Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling.: 2026 ApoE mouse cardiac-remodeling study: mitochondria-targeted esculetin activates AMPK in aged/hypercholesterolemic hearts with metformin-comparable anti-hypertrophic/anti-fibrotic effects, adding a mitochondria-targeted small molecule to the AMPK-engaging preclinical roster — no mTOR readout, no human data. [animal-model] (novelty: 3)
- 2026-09-10 — EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial.: Pilot single-arm human trial (4 weeks, 1 mg/day rapamycin) in healthy middle-aged APOE4 carriers reports systemic metabolic and inflammatory shifts alongside cerebral blood flow gains — first genotype-stratified human mTOR-inhibition signal at low, weekly-adjacent oral dosing, but uncontrolled and 4 weeks only. [human-rct] (novelty: 3)
- 2026-08-24 — Qinghuang powder ameliorates cellular senescence and energy metabolism abnormalities in bone marrow mesenchymal stem cells of myelodysplastic syndromes.: 2026 in vitro MDS-BMMSC study nominates AMPK activation by Qinghuang powder components (AsS, indirubin) as the nutrient-sensing arm coupling TCM treatment to reduced stromal senescence and restored energy metabolism in a hematologic-niche disease context — cell-culture only, no in vivo mTOR/AMPK readouts. [mechanism-plausible] (novelty: 3)
- 2026-09-09 — Copper and iron engage distinct metabolic programs for cellular survival.: Yeast nutrient-limitation study finds iron-supported long-term survival depends on a TORC1-permissive state that rapamycin abolishes, adding a micronutrient (iron availability) as an upstream gate on TORC1’s pro-survival tone distinct from amino-acid inputs — preclinical, yeast only. [animal-model] (novelty: 3)
- 2026-08-14 — Targeting TWEAK to enhance mitochondrial biogenesis and attenuate age-related muscle mass loss.: Aged-mouse muscle TWEAK knockdown activates AMPK to drive mitochondrial biogenesis and attenuate sarcopenia, adding a cytokine-suppression route into the AMPK arm of nutrient sensing distinct from CR or metformin — preclinical, no mTOR readout. [animal-model] (novelty: 3)
- 2026-09-05 — Midlife Growth Hormone Receptor Ablation Extends Healthy Lifespan and Induces Sex‐Specific Hepatic Transcriptional Changes at Single‐Cell Resolution: cross-connection with growth-hormone-igf1-axis: GHR ablation reduces IGF-1 signaling upstream of PI3K/AKT/mTOR; midlife-onset benefit parallels midlife rapamycin evidence in the nutrient-sensing axis. (novelty: 3)
- 2026-04-13 — The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.: 2026 GLAM-framework review names AMPK/mTOR as one of three shared molecular modules (with mtROS–p53 and AcCoA–HAT) coordinating multi-organ metabolic-inflammatory aging around sarcopenia — synthesis, no new nutrient-sensing data. [expert-opinion] (novelty: 3)
- 2026-04-15 — Dietary geroprotective peptides: structural determinants, AI-driven discovery, and synthetic biology production for healthy ageing.: 2026 review synthesizes food-derived bioactive peptides (plant/animal/marine) as putative geroprotectors acting partly via IIS and mTOR modulation, proposing AI-driven discovery and synthetic-biology production as a scale-up route — narrative synthesis with structure–activity framing, no new outcome data. [expert-opinion] (novelty: 3)
- 2026-06-23 — Bound polyphenols from carrot dietary fiber delay aging inthrough the IIS pathway and metabolic remodeling.: C. elegans study: bound polyphenols from carrot dietary fiber (CDF-BP) extended mean lifespan ~26% and improved healthspan via insulin/IGF-1 signaling (DAF-16/SKN-1) and metabolic remodeling — adds a fiber-bound polyphenol angle to the IIS/nutrient-sensing longevity roster, worm-only. [animal-model] (novelty: 3)
- 2026-06-29 — Resveratrol exerts stage- and sex-specific anti-aging and multigenerational effects via epigenetic and metabolic pathways in Drosophila.: Drosophila study: adult resveratrol (50 μg/ml) extended female lifespan and improved healthspan partly via metabolic reprogramming consistent with nutrient-sensing (mTOR/AMPK) modulation, while embryonic exposure shortened adult lifespan — reinforces the stage- and sex-dependent nutrient-sensing pattern already seen with luteolin in flies. [animal-model] (novelty: 3)
- 2026-07-11 — From local to systemic: Spinal aging in the multi-organ aging network.: 2026 spinal-aging review lists deregulated nutrient sensing (mTOR-centric) among the hallmark axes upstream of intervertebral disc degeneration and paraspinal sarcopenia, framing spine health as a downstream readout of systemic nutrient-sensing tone — narrative synthesis, no new data. [expert-opinion] (novelty: 3)
- 2026-07-29 — Complosome as a key modulator of cellular senescence, aging and age-related diseases.: 2026 complosome review argues intracellular C3/C5 crosstalks bidirectionally with mTOR (and AMPK) signaling in senescent and aged cells, nominating intracellular complement as an unappreciated modulator of nutrient-sensing tone — conceptual framing only. [expert-opinion] (novelty: 3)
- 2026-08-10 — Transcriptomics reveals species-specific adaptive strategies to calorie restriction in two Argopecten scallops with distinct lifespans.: Comparative transcriptomics in two Argopecten scallop species under CR: mTOR/S6K suppression appears conserved across short- and long-lived species, positioning it as a core CR-responsive nutrient-sensing node even in bivalves, though the longevity link remains correlational. [animal-model] (novelty: 3)
- 2026-08-26 — Rapamycin attenuates age-related atrial remodeling and fibrillation by targeting HIF-1α-mediated metabolic dysregulation.: D-galactose aging mouse model: rapamycin reduced atrial fibrillation susceptibility and atrial electrical/structural remodeling by suppressing HIF-1α–driven metabolic dysregulation, with the authors noting effects that appear partly mTOR-independent (direct HIF-1α interference), complicating a pure mTOR-centric read of rapamycin’s cardiac-aging benefit. [animal-model] (novelty: 3)
- 2026-09-01 — Solute Carrier Family 1 Member 5 (SLC1A5)-dependent glutamine transport regulates macrophage senescence and efferocytosis during liver regeneration.: cross-connection with cellular-senescence: SLC1A5-mediated glutamine transport (a canonical mTORC1-activating amino-acid input) gates macrophage senescence in regenerating liver, linking nutrient-sensing amino-acid flux to tissue-specific senescence control. (novelty: 3)
- 2026-08-20 — Luteolin promotes healthy aging in adult females but shortens lifespan after embryonic exposure in.: Model-organism study: adult luteolin supplementation extended median lifespan ~11.6% and improved healthspan in females via engagement of nutrient-sensing (and antioxidant/autophagy) pathways, while embryonic exposure shortened lifespan and disrupted endocrine-metabolic homeostasis — sex- and developmental-stage-dependent effect of a dietary flavonoid on nutrient-sensing. [animal-model] (novelty: 3)
- 2026-07-01 — A critical role for mitochondrial dynamics in cigarette smoke condensate-induced RPE senescence.: 2026 RPE + chronic smoke-exposed mouse study finds mTOR activation downstream of cigarette-smoke-induced mitochondrial dynamics failure, positioning mTOR as a convergence node between environmental oxidative stress and tissue-specific senescence in the retina. [animal-model] (novelty: 3)
- 2026-06-29 — Mammalian aging involves genome-wide splicing degeneration leading to functional decline.: 2026 splicing-fidelity analysis reports that rapamycin (and CR) attenuate age-associated splicing degeneration in mouse tissues, extending mTOR-suppression’s proposed reach to RNA processing fidelity — observational/preclinical, mechanism-level. [animal-model] (novelty: 3)
- 2026-07-01 — High Intrinsic Aerobic Capacity Is Associated With a Distinct Epigenetic and Signaling Profile in the Aged Rat Brain.: 2026 aged-rat study: high intrinsic (untrained) aerobic capacity tracks a distinct cortical AKT-mTOR-S6 and MAPK signaling profile alongside synaptic and inflammation-related changes, suggesting baseline cardiorespiratory fitness sets nutrient-sensing tone in the aged brain independent of training. [animal-model] (novelty: 3)
- 2026-06-29 — Mechanistic redundancy and hierarchy of aging mechanisms: implications for strategies to extend healthspan and biomarker integration.: 2026 hierarchy review positions deregulated nutrient sensing as a downstream hallmark within a primary/secondary/tertiary schema, arguing mTOR-directed interventions alone are insufficient without coordinated targeting of primary drivers such as genomic damage and sex-hormone decline — review-level framing, no new data. [expert-opinion] (novelty: 3)
- 2026-07-17 — Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance.: 2026 adult-onset muscle-specific Depdc5 (GATOR1) knockout in mice: constitutive mTORC1 activation in skeletal muscle drove inflammatory/immune transcriptional remodeling but was insufficient to impair systemic glucose tolerance even on a Western diet, dissociating muscle mTORC1 hyperactivation from the assumed insulin-resistance phenotype. [animal-model] (novelty: 3)
- 2026-07-19 — Rethinking frailty as a disorder of mitochondrial adaptability, from energetic congestion to systemic vulnerability.: 2026 frailty perspective argues chronic anabolic/substrate oversupply (implicating mTOR-driven nutrient sensing) relative to declining energetic demand generates ‘energetic congestion’ that impairs mitochondrial adaptability, reframing the frailty nutrition debate away from energy supplementation toward demand-side (exercise) engagement of nutrient-sensing pathways — perspective only, no new data. [expert-opinion] (novelty: 3)
- 2026-07-01 — Gut Metabolism Links Precision Nutrition, Exercise, and Healthspan in Drosophila melanogaster.: 2026 Drosophila study: methionine restriction combined with taurine and moderate exercise additively extends lifespan without fecundity/locomotor trade-offs, consistent with methionine-sensing (mTOR/amino-acid) inputs being modulable by co-interventions in flies. [animal-model] (novelty: 3)
- 2026-08-01 — Methionine tuning for health without frailty.: 2026 commentary on Fanti et al. argues moderate methionine add-back to a low-protein Mediterranean-style diet engages a GH–GLP-1–FGF21 endocrine axis that cuts adiposity and frailty without CR, refining the protein-quality-vs-quantity picture of mTOR/amino-acid sensing — commentary on mouse work, no human outcome data. [animal-model] (novelty: 3)
- 2026-08-11 — Pentadecanoic acid as a potential endogenous mTOR modulator for age-related female infertility: Mechanistic insights, molecular docking evidence, and therapeutic perspectives.: 2026 review proposes pentadecanoic acid (C15:0) as a pregnancy-compatible endogenous mTOR modulator for ovarian aging, arguing via AMPK/PPAR links and molecular docking (vs rapamycin) that it could dampen mTOR signaling in aging oocytes — no human or animal fertility outcome data. [mechanism-plausible] (novelty: 3)
- 2026-08-01 — An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline.: 2026 study places ANGPTL8 upstream of an AKT2–mTOR–S6K axis in adipose tissue, connecting a circulating hepatokine/adipokine to mTOR-driven senescence; mouse Angptl8 KO lifespan extension plus human cohort associations with biological age and mortality, but no interventional human data. [animal-model] (novelty: 4)
- 2026-08-17 — Protein restriction and the hallmarks of aging: A coordinated physiological adaptive response?: 2026 review reframes protein restriction’s cross-species longevity effect as a single coordinated adaptive response, with cellular amino-acid/nutrient sensing (mTORC1, GCN2, ATF4) as the proximal trigger integrated with endocrine and neural signaling — synthesis, no new outcome data. [expert-opinion] (novelty: 3)
- 2026-08-17 — Gut microbial load mediates the longevity effect of Korean red ginseng in Drosophila melanogaster.: Drosophila study: Korean red ginseng extends lifespan by lowering total gut microbial load, and this reduction is required for KRG’s downstream modulation of insulin/IGF-1 signaling (IIS) and Sir2 — positioning microbial load as an upstream gate on nutrient-sensing pathway effects, but only in flies. [animal-model] (novelty: 3) [animal-model] (novelty: 3)
- 2026-08-17 — Epigenetic Skeletal Muscle Memory: The Impact of Physical Activity on Aging and Post-Injury Regeneration.: Review notes load-induced mTOR/anabolic signaling as an upstream trigger for the transcriptional and epigenetic priming underlying muscle memory, without new intervention data on the pathway. [mechanism-plausible] (novelty: 3)
- 2026-09-02 — Mitochondrial Microautophagy: An Emerging Pathway in Maintaining Mitochondrial Homeostasis.: Review touches nutrient/stress-sensing upstream regulation of mitochondrial microautophagy but provides no new data linking mTOR modulation to this specific sub-pathway; connection remains inferential. [mechanism-plausible] (novelty: 3)
- 2026-07-31 — Early life sugar rationing and ageing related diseases, biological ageing and mortality.: UK Biobank natural experiment on post-war sugar rationing (exposure during first 1,000 days) linked to ~9% lower hallmark-related disease incidence, ~19% lower all-cause mortality, and 1.0–1.2 years younger biological age across multiple clocks, with proteomic shifts aligned to AMPK activation and mTOR suppression — human observational, confounding by cohort/period effects not fully excluded. [human-observational] (novelty: 4)
Open questions
Related
Contributing findings
Sex, but not age, drives transcriptome-wide gene expression variation in a turtle with female-biased longevity.
14-nov-2026
novelty 3
per-area 2
mentions
Functional contribution of TERT to mitigation of endometrial stromal cell senescence by metformin through modulation of the AKT/mTOR axis.
13-nov-2026
novelty 3
per-area 3
strengthens
Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation.
13-nov-2026
novelty 3
per-area 3
strengthens
Protein and Longevity: Does High Protein Accelerate Aging?
12-nov-2026
novelty 2
per-area 1
mentions
Eating less protein could slow aging, review of 350 studies finds
10-nov-2026
novelty 2
per-area 2
mentions
Epigenetic age acceleration in the brain and blood of people with epilepsy and in a mouse model of focal cortical dysplasia: a retrospective cross-sectional study.
09-nov-2026
novelty 3
per-area 3
strengthens
Adipocyte FGF21 signalling connects protein restriction and metabolic cellular ageing.
06-nov-2026
novelty 3
per-area 3
strengthens
Rapamycin and human longevity among kidney transplant recipients surviving the first year.
05-nov-2026
novelty 4
per-area 4
strengthens
Longitudinal associations between the hallmarks of aging and body composition: a narrative review.
04-nov-2026
novelty 3
per-area 3
strengthens
Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1-Dependent Suppression of ROMK.
01-nov-2026
novelty 3
per-area 3
strengthens
Constitutive Activation of Skeletal Muscle mTORC1 Drives Pro-Inflammatory Gene Expression in Skeletal Muscle of Aged Mice.
01-nov-2026
novelty 3
per-area 3
strengthens
Whey protein hydrolysate rich in branched-chain amino acid-containing oligopeptide as a novel nutritional strategy to attenuate age-related muscle weakness.
30-oct-2026
novelty 3
per-area 2
strengthens
Deciphering adipaging in Drosophila: Exploring carotenoid-mediated regulation of aging and metabolism.
23-oct-2026
novelty 2
per-area 1
mentions
Human serum collected after fermented whey protein supplementation stimulates myocellular growth and protein synthesis: A randomized, double-blind, active-controlled crossover trial.
23-oct-2026
novelty 3
per-area 2
strengthens
Cell type-dependent activation of autophagic flux by D-amino acids.
19-oct-2026
novelty 3
per-area 3
strengthens
The mechanism of dietary intervention in delaying brain aging and neurodegenerative diseases.
13-oct-2026
novelty 2
per-area 2
strengthens
Correction to "AMPK-upregulated microRNA-708 Plays as a Suppressor of Cellular Senescence and Aging via Downregulating Disabled-2 and mTORC1 Activation".
13-oct-2026
novelty 1
per-area 1
mentions
Adropin signaling pathways in metabolic and non-metabolic disorders.
10-oct-2026
novelty 2
per-area 2
mentions
Sulfur amino acid restriction and caloric restriction induce divergent redox metabolism-related adaptations in male F344 rats.
10-oct-2026
novelty 3
per-area 2
mentions
Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus).
09-oct-2026
novelty 3
per-area 2
strengthens
Is there a role for senotherapeutics in the treatment of giant cell arteritis?
07-oct-2026
novelty 2
per-area 2
mentions
Decoding Ginsenosides: The Structural and Therapeutic Core of Ginseng.
07-oct-2026
novelty 2
per-area 1
mentions
Direct Pharmacological Activation of AMPK Modestly Extends Life in Short-Lived Species
07-oct-2026
novelty 2
per-area 2
strengthens
PI3K is the dominant signalling pathway recruited by IRS proteins to mediate their effects on metabolism and growth.
06-oct-2026
novelty 3
per-area 3
strengthens
Caloric restriction mimetics rewire the AMPK-mTOR-ULK1 signaling nexus to restore autophagic proteostasis in the aging brain.
05-oct-2026
novelty 2
per-area 2
strengthens
Fight Aging! Newsletter, October 5th 2026
04-oct-2026
novelty 2
per-area 2
strengthens
From in silico to in vivo: The possibilities and limitations of systems modelling in understanding age-associated anabolic resistance.
02-oct-2026
novelty 2
per-area 2
mentions
Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice.
01-oct-2026
novelty 3
per-area 3
strengthens
Traditional Chinese medicine-derived natural products and formulations as pharmacological modulators of ageing-related pathways: mechanisms and therapeutic potential.
01-oct-2026
novelty 2
per-area 2
mentions
Direct Pharmacological Activation of AMPK Extends Lifespan in Yeast, Worms and Flies
29-sep-2026
novelty 3
per-area 3
strengthens
Musculoskeletal decay and bone-muscle crosstalk during physical disuse: Mechanisms and integrated countermeasures.
28-sep-2026
novelty 2
per-area 2
mentions
Berberine as a multi-hallmark modulator of aging: From AMPK and mitophagy to inflammaging and the SASP.
28-sep-2026
novelty 2
per-area 2
strengthens
Lifespan-extending downregulation of insulin signalling reduces germline mutation load
27-sep-2026
novelty 4
per-area 4
strengthens
Stem cell senescence as a regenerative bottleneck in age-related skeletal degeneration: Mechanistic crosstalk and translational strategies.
27-sep-2026
novelty 2
per-area 2
mentions
Developing Metal-Polyphenol Network-Based Single-Protein Particle Encapsulation System for Sustained Release of Whey Protein to Mitigate Sarcopenia.
27-sep-2026
novelty 3
per-area 2
mentions
Perilla frutescens extract reduces fat accumulation and promotes longevity in Caenorhabditis elegans via modulation of the insulin/IGF-1 signaling pathway.
26-sep-2026
novelty 2
per-area 2
strengthens
Neuroenergetic Flexibility in the Aging Brain: Cellular Mechanisms and Diet-Induced Metabolic Switching.
26-sep-2026
novelty 3
per-area 2
mentions
Mitochondrial-Targeted Phytochemicals in Reproductive Aging: Mechanisms and Translational Potential.
25-sep-2026
novelty 2
per-area 2
mentions
Sirtuin signaling as therapeutic targets of immunosenescence.
25-sep-2026
novelty 2
per-area 2
mentions
Autophagy in sarcopenic obesity: muscle-adipose crosstalk, metabolic regulation, and exercise-based interventions.
24-sep-2026
novelty 2
per-area 2
strengthens
Rapamycin across biology and medicine: From molecular mechanisms to clinical and translational frontiers.
24-sep-2026
novelty 2
per-area 2
strengthens
Parishin B, a phenolic constituent of Gastrodia elata Blume, extends lifespan and improves stress resistance in Caenorhabditis elegans.
23-sep-2026
novelty 3
per-area 2
mentions
Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice
23-sep-2026
novelty 3
per-area 3
strengthens
Lsp2 links early-life diet to adult translation and lifespan in Drosophila.
23-sep-2026
novelty 3
per-area 3
strengthens
Lsp2 links mTORC1 to TOP mRNA translation and lifespan in Drosophila.
23-sep-2026
novelty 4
per-area 4
strengthens
Tissue-specific aging clocks map structured aging-modulatory drug-score patterns across 49 human tissue and cell-line categories.
22-sep-2026
novelty 3
per-area 2
mentions
Nanoparticle-Based Tools to Study Hallmarks of Aging at the Molecular Level.
22-sep-2026
novelty 2
per-area 2
mentions
Immunosenescence in Uveitis: From Mechanistic Insights to Therapeutic Implications.
22-sep-2026
novelty 2
per-area 2
mentions
Mechanisms of Brain Aging and Their Links to Alzheimer's and Parkinson's Disease Pathology.
21-sep-2026
novelty 2
per-area 2
strengthens